[1] E. Rinninella et al., "What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases," (in eng), Microorganisms, vol. 7, no. 1, Jan 2019, doi: 10.3390/microorganisms7010014.
[2] R. E. Ley, F. Bäckhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight, and J. I. Gordon, "Obesity alters gut microbial ecology," (in eng), Proc Natl Acad Sci U S A, vol. 102, no. 31, pp. 11070-5, Aug 2005, doi: 10.1073/pnas.0504978102.
[3] R. E. Ley, P. J. Turnbaugh, S. Klein, and J. I. Gordon, "Microbial ecology: human gut microbes associated with obesity," (in eng), Nature, vol. 444, no. 7122, pp. 1022-3, Dec 2006, doi: 10.1038/4441022a.
[4] P. D. Cani, "Human gut microbiome: hopes, threats and promises," (in eng), Gut, vol. 67, no. 9, pp. 1716-1725, 09 2018, doi: 10.1136/gutjnl-2018-316723.
[5] E. Da Pozzo et al., "Antioxidant and Antisenescence Effects of Bergamot Juice," (in eng), Oxid Med Cell Longev, vol. 2018, p. 9395804, 2018, doi: 10.1155/2018/9395804.
[6] M. Gliozzi et al., "Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia," (in eng), Int J Cardiol, vol. 170, no. 2, pp. 140-5, Dec 2013, doi: 10.1016/j.ijcard.2013.08.125.
[7] P. P. Toth et al., "Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study," (in eng), Front Pharmacol, vol. 6, p. 299, 2015, doi: 10.3389/fphar.2015.00299.
[8] C. Formisano et al., "Detailed Phytochemical Characterization of Bergamot Polyphenolic Fraction (BPF) by UPLC-DAD-MS and LC-NMR," (in eng), J Agric Food Chem, vol. 67, no. 11, pp. 3159-3167, Mar 2019, doi: 10.1021/acs.jafc.8b06591.
[9] V. Mollace et al., "Hypoglycemic and Hypolipemic Effects of a New Lecithin Formulation of Bergamot Polyphenolic Fraction: A Double Blind, Randomized, Placebo- Controlled Study," (in eng), Endocr Metab Immune Disord Drug Targets, vol. 19, no. 2, pp. 136-143, 2019, doi: 10.2174/1871530319666181203151513.
[10] M. O. Hill, "Diversity and Evenness: A Unifying Notation and Its Consequences," Ecology, vol. 54, no. 2, pp. 427-432, 1973, doi: 10.2307/1934352.
[11] A. Koliada et al., "Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population," (in eng), BMC Microbiol, vol. 17, no. 1, p. 120, 05 2017, doi: 10.1186/s12866-017-1027-1.
[12] S. E. Chiuve et al., "Lifestyle-based prediction model for the prevention of CVD: the Healthy Heart Score," (in eng), J Am Heart Assoc, vol. 3, no. 6, p. e000954, Nov 2014, doi: 10.1161/JAHA.114.000954.
[13] Y. Sanz, A. Santacruz, and G. De Palma, "Insights into the roles of gut microbes in obesity," (in eng), Interdiscip Perspect Infect Dis, vol. 2008, p. 829101, 2008, doi: 10.1155/2008/829101.
[14] P. Gérard, "Gut microbiota and obesity," (in eng), Cell Mol Life Sci, vol. 73, no. 1, pp. 147-62, Jan 2016, doi: 10.1007/s00018-015-2061-5.
[15] S. Ussar et al., "Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome," (in eng), Cell Metab, vol. 22, no. 3, pp. 516-530, Sep 2015, doi: 10.1016/j.cmet.2015.07.007.
[16] M. Serino et al., "Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota," (in eng), Gut, vol. 61, no. 4, pp. 543-53, Apr 2012, doi: 10.1136/gutjnl-2011-301012.
[17] P. J. Turnbaugh, V. K. Ridaura, J. J. Faith, F. E. Rey, R. Knight, and J. I. Gordon, "The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice," (in eng), Sci Transl Med, vol. 1, no. 6, p. 6ra14, Nov 2009, doi: 10.1126/scitranslmed.3000322.
[18] E. Le Chatelier et al., "Richness of human gut microbiome correlates with metabolic markers," (in eng), Nature, vol. 500, no. 7464, pp. 541-6, Aug 2013, doi: 10.1038/nature12506.
[19] A. F. G. Cicero, F. Fogacci, M. Bove, M. Giovannini, and C. Borghi, "Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects," (in eng), Phytother Res, vol. 33, no. 8, pp. 2094-2101, Aug 2019, doi: 10.1002/ptr.6402.
[20] A. Riva, M. Ronchi, G. Petrangolini, S. Bosisio, and P. Allegrini, "Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin," (in eng), Eur J Drug Metab Pharmacokinet, vol. 44, no. 2, pp. 169-177, Apr 2019, doi: 10.1007/s13318-018-0517-3.
[21] G. Petrangolini, M. Ronchi, E. Frattini, E. De Combarieu, P. Allegrini, and A. Riva, "A New Food-grade Coenzyme Q10 Formulation Improves Bioavailability: Single and Repeated Pharmacokinetic Studies in Healthy Volunteers," (in eng), Curr Drug Deliv, vol. 16, no. 8, pp. 759-767, 2019, doi: 10.2174/1567201816666190902123147.
[22] V. Dinakaran, A. Rathinavel, M. Pushpanathan, R. Sivakumar, P. Gunasekaran, and J. Rajendhran, "Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation," (in eng), PLoS One, vol. 9, no. 8, p. e105221, 2014, doi: 10.1371/journal.pone.0105221.
[23] M. Luedde et al., "Heart failure is associated with depletion of core intestinal microbiota," (in eng), ESC Heart Fail, vol. 4, no. 3, pp. 282-290, Aug 2017, doi: 10.1002/ehf2.12155.
[24] J. Libertucci et al., "Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease," (in eng), Am J Physiol Gastrointest Liver Physiol, vol. 315, no. 3, pp. G420-G431, 09 2018, doi: 10.1152/ajpgi.00411.2017.
[25] T. H. Luu, C. Michel, J. M. Bard, F. Dravet, H. Nazih, and C. Bobin-Dubigeon, "Intestinal Proportion of Blautia sp. is Associated with Clinical Stage and Histoprognostic Grade in Patients with Early-Stage Breast Cancer," (in eng), Nutr Cancer, vol. 69, no. 2, pp. 267-275, 2017 Feb-Mar 2017, doi: 10.1080/01635581.2017.1263750.
[26] E. Nistal et al., "An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity," (in eng), Rev Esp Enferm Dig, vol. 111, no. 4, pp. 275-282, Apr 2019, doi: 10.17235/reed.2019.6068/2018.
[27] N. Ozato et al., "genus associated with visceral fat accumulation in adults 20-76 years of age," (in eng), NPJ Biofilms Microbiomes, vol. 5, p. 28, 2019, doi: 10.1038/s41522-019-0101-x.
[28] R. Gao et al., "Dysbiosis Signatures of Gut Microbiota Along the Sequence from Healthy, Young Patients to Those with Overweight and Obesity," (in eng), Obesity (Silver Spring), vol. 26, no. 2, pp. 351-361, 02 2018, doi: 10.1002/oby.22088.
[29] S. Verhoog et al., "Dietary Factors and Modulation of Bacteria Strains of," (in eng), Nutrients, vol. 11, no. 7, Jul 2019, doi: 10.3390/nu11071565.
[30] M. Minekus et al., "A standardised static in vitro digestion method suitable for food - an international consensus," (in eng), Food Funct, vol. 5, no. 6, pp. 1113-24, Jun 2014, doi: 10.1039/c3fo60702j.
[31] S. Hollebeeck, F. Borlon, Y. J. Schneider, Y. Larondelle, and H. Rogez, "Development of a standardised human in vitro digestion protocol based on macronutrient digestion using response surface methodology," (in eng), Food Chem, vol. 138, no. 2-3, pp. 1936-44, Jun 2013, doi: 10.1016/j.foodchem.2012.11.041.
[32] Q. Wang, G. M. Garrity, J. M. Tiedje, and J. R. Cole, "Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy," (in eng), Appl Environ Microbiol, vol. 73, no. 16, pp. 5261-7, Aug 2007, doi: 10.1128/AEM.00062-07.
[33] A. Borovecki, A. Mlinaric, M. Horvat, V. Supak Smolcic. Informed consent and ethics committee approval in laboratory medicine. Biochem Med (Zagreb).2018 Oct 15;28(3):030201. doi: 10.11613/BM.2018.030201. Review.